Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2023 | Applying industry standards to improve the efficiency of drug development

Kent Hendrix, BS, Pentara Corporation, Salt Lake City, UT, comments on advancements in clinical trial conduction to improve efficiency and data quality. CDISC standards are required for regulatory submissions to the US FDA, as well as numerous other global regulatory agencies. Mr Hendrix comments on the importance of adhering to these industry standards from as early in the drug development process as possible, in order to streamline workflows. Standards exist for research planning, data collection and organization, analysis, and data exchange, supporting clinical research processes from end to end. As well as expediting the drug development process, following industry standards supports data sharing and data science by ensuring accessibility, interoperability, and re-useability. This interview took place at the Alzheimer’s Association International Conference® (AAIC) 2023 in Amsterdam, Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Kent Hendrix is a principal and Senior VP of Pentara Corporation, a company which consults with dozens of companies in the Alzheimer’s space, including Eisai, Biogen, Lilly, and Nutricia.